Skip to main content
. Author manuscript; available in PMC: 2023 Jul 24.
Published in final edited form as: J Clin Rheumatol. 2021 Apr 1;27(3):87–91. doi: 10.1097/RHU.0000000000001170

TABLE 3.

Laboratory Values

Active Untreated JIA (n = 27) Quiescent Treated JIA (n = 32) Healthy Controls (n = 16) Bacteremic Patients (n = 17) p value
White blood cells, ×109/L 7.0 (5.6, 8.2) 7.4 (6.2, 8.2) 6.9 (5.3, 8.4) 7.7 (4.9, 13.0) 0.72
Hemoglobin, g/dL 12.6 (11.9, 13.3) 13.1 (12.4, 13.9) 14.0 (12.5, 14.3) 9.9 (9.3, 11.1) <0.001
Platelets, ×109/L
ESR, mm/h
288 (248, 353)
10 (6, 20)
273 (218, 308)
6 (2, 10)
293 (243, 316)
8 (5, 10)
200 (148, 259)
50 (27, 67)
0.004
<0.001
CRP, mg/dL 1.40 (0.12, 5.20) 0.18 (0.06, 0.57) 0.42 (0.14, 1.56) 10.45 (3.80, 17.40) <0.001
PCT, μg/mL 0 (0, 0) 0 (0, 0) 0 (0, 0) 6.68 (1.93, 21.58) <0.001

Values are presented as median (interquartile range).